SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-040589
Filing Date
2024-03-28
Accepted
2024-03-28 16:51:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm249820d2_s3.htm S-3 214211
2 EXHIBIT 5.1 tm249820d2_ex5-1.htm EX-5.1 9831
3 EXHIBIT 23.1 tm249820d2_ex23-1.htm EX-23.1 2200
4 EX-FILING FEES tm249820d2_exfilingfees.htm EX-FILING FEES 23520
5 GRAPHIC tm249820d2_ex5-1img01.jpg GRAPHIC 2702
6 GRAPHIC tm249820d2_ex5-1img02.jpg GRAPHIC 1532
  Complete submission text file 0001104659-24-040589.txt   257247
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278337 | Film No.: 24799981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)